BRIMONIDINE/TIMOLOL VIATRIS 2 mg/ml + 5 mg/ml, eye drop solution bottle, 5 ml
Active ingredients: Brimonidine, Timolol maleate, Brimonidine tartrate, TIMOLOL
Commercialized according to BDPMDispensing in France: Prescription only
Eye drop solutionbottle, 5 mlophtalmique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BRIMONIDINE/TIMOLOL VIATRIS 2 mg/ml + 5 mg/ml, collyre en solution
- Pharmaceutical form
- collyre en solution
- Route of administration
- ophtalmique
- Presentation description
- 1 flacon(s) polyéthylène basse densité (PEBD) de 5 ml
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 18 Jan 2021
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65492389CIP73014097CIP133400930140970Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MALÉATE DE TIMOLOLcollyre | 6,8 mg · 1 ml de solution | SA |
| TIMOLOLcollyre | 5 mg · 1 ml de solution | FT |
| BRIMONIDINEcollyre | 1,3 mg · 1 ml de solution | FT |
| TARTRATE DE BRIMONIDINEcollyre | 2 mg · 1 ml de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.